Crimean-Congo hemorrhagic fever (CCHF) is a zoonosis caused by a Nairovirus of the family Bunyaviridae. Infection is transmitted to humans mostly by Hyalomma ticks and also by direct contact with the blood or tissues of infected humans or viremic livestock. Clinical features usually include a rapid progression characterized by hemorrhage, myalgia and fever, with a lethality rate up to 30%. CCHF is one of the most widely distributed viral hemorrhagic fevers and has been reported in Africa, the Middle East and Asia, as well as parts of Europe. There is no approved vaccine or specific treatment against CCHF virus (CCHFV) infections. In this context, an accurate diagnosis as well as a reliable surveillance of CCHFV infections is essential. Diagnostic techniques include virus culture, serology and molecular methods, which are now increasingly used. The European Network for the Diagnostics of “Imported” Viral Diseases organized the first international external quality assessment of CCHVF molecular diagnostics in 2011 to assess the efficiency and accurateness of CCHFV molecular methods applied by expert laboratories. A proficiency test panel of 15 samples was distributed to the participants including 10 different CCHFV preparations generated from infected cell cultures, a preparation of plasmid cloned with the nucleoprotein of CCHFV, two CCHFV RNA preparations and two negative controls. Forty-four laboratories worldwide participated in the EQA study and 53 data sets were received. Twenty data sets (38%) met all criteria with optimal performance, 10 (19%) with acceptable performance, while 23 (43%) reported results showing a need for improvement. Differences in performance depended on the method used, the type of strain tested, the concentration of the sample tested and the laboratory performing the test. These results indicate that there is still a need for improving testing conditions and standardizing protocols for the molecular detection of Crimean-Congo hemorrhagic fever virus.
References
[1]
Whitehouse CA (2004) Crimean-Congo hemorrhagic fever. Antiviral Res 64: 145–160. doi: 10.1016/j.antiviral.2004.08.001
[2]
Vorou R, Pierroutsakos IN, Maltezou HC (2007) Crimean-Congo hemorrhagic fever. Curr Opin Infect Dis 20: 495–500. doi: 10.1097/QCO.0b013e3282a56a0a
Maltezou HC, Andonova L, Andraghetti R, Bouloy M, Ergonul O, et al. (2010) Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness. Euro Surveill 15: 19504.
[5]
Papa A, Christova I, Papadimitriou E, Antoniadis A (2004) Crimean-Congo hemorrhagic fever in Bulgaria. Emerg Infect Dis 10: 1465–1467. doi: 10.3201/eid1008.040162
[6]
Christova I, Di Caro A, Papa A, Castilletti C, Andonova L, et al. (2009) Crimean-Congo hemorrhagic fever, southwestern Bulgaria. Emerg Infect Dis 15: 983–985. doi: 10.3201/eid1506.081567
[7]
Kunchev A, Kojouharova M (2008) Probable cases of Crimean-Congo-haemorrhagic fever in Bulgaria: a preliminary report. Euro Surveill 13:
[8]
Papa A, Bino S, Papadimitriou E, Velo E, Dhimolea M, et al. (2008) Suspected Crimean Congo Haemorrhagic Fever cases in Albania. Scand J Infect Dis 40: 978–980. doi: 10.1080/00365540802144125
[9]
Papa A, Bino S, Llagami A, Brahimaj B, Papadimitriou E, et al. (2002) Crimean-Congo hemorrhagic fever in Albania, 2001. Eur J Clin Microbiol Infect Dis 21: 603–606. doi: 10.1007/s10096-002-0770-9
[10]
Humolli I, Dedushaj I, Zupanac TA, Mucaj S (2010) Epidemiological, serological and herd immunity of Crimean-Congo haemorrhagic fever in Kosovo. Med Arh 64: 91–93.
[11]
Papa A, Bozovi B, Pavlidou V, Papadimitriou E, Pelemis M, et al. (2002) Genetic detection and isolation of crimean-congo hemorrhagic fever virus, Kosovo, Yugoslavia. Emerg Infect Dis 8: 852–854. doi: 10.3201/eid0805.010448
[12]
Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, et al. (2009) The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007. Int J Infect Dis 13: 380–386. doi: 10.1016/j.ijid.2008.07.021
[13]
Ertugrul B, Uyar Y, Yavas K, Turan C, Oncu S, et al. (2009) An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey. Int J Infect Dis 13: e431–436. doi: 10.1016/j.ijid.2009.02.011
[14]
Gargili A, Midilli K, Ergonul O, Ergin S, Alp HG, et al. (2011) Crimean-Congo hemorrhagic fever in European part of Turkey: genetic analysis of the virus strains from ticks and a seroepidemiological study in humans. Vector Borne Zoonotic Dis 11: 747–752. doi: 10.1089/vbz.2010.0030
[15]
Papa A, Maltezou HC, Tsiodras S, Dalla VG, Papadimitriou T, et al. (2008) A case of Crimean-Congo haemorrhagic fever in Greece, June 2008. Euro Surveill 13:
[16]
Jaureguiberry S, Tattevin P, Tarantola A, Legay F, Tall A, et al. (2005) Imported Crimean-Congo hemorrhagic Fever. J Clin Microbiol 43: 4905–4907. doi: 10.1128/JCM.43.9.4905-4907.2005
[17]
Midilli K, Gargili A, Ergonul O, Sengoz G, Ozturk R, et al. (2007) Imported Crimean-Congo hemorrhagic fever cases in Istanbul. BMC Infect Dis 7: 54. doi: 10.1186/1471-2334-7-54
[18]
Morikawa S, Saijo M, Kurane I (2007) Recent progress in molecular biology of Crimean-Congo hemorrhagic fever. Comp Immunol Microbiol Infect Dis 30: 375–389. doi: 10.1016/j.cimid.2007.07.001
[19]
Ibrahim SM, Aitichou M, Hardick J, Blow J, O'Guinn ML, et al. (2011) Detection of Crimean-Congo hemorrhagic fever, Hanta, and sandfly fever viruses by real-time RT-PCR. Methods Mol Biol 665: 357–368. doi: 10.1007/978-1-60761-817-1_19
[20]
Kondiah K, Swanepoel R, Paweska JT, Burt FJ (2010) A Simple-Probe real-time PCR assay for genotyping reassorted and non-reassorted isolates of Crimean-Congo hemorrhagic fever virus in southern Africa. J Virol Methods 169: 34–38. doi: 10.1016/j.jviromet.2010.06.010
[21]
Duh D, Saksida A, Petrovec M, Dedushaj I, Avsic-Zupanc T (2006) Novel one-step real-time RT-PCR assay for rapid and specific diagnosis of Crimean-Congo hemorrhagic fever encountered in the Balkans. J Virol Methods 133: 175–179. doi: 10.1016/j.jviromet.2005.11.006
[22]
Niedrig M, Zeller H, Schuffenecker I, Drosten C, Emmerich P, et al. (2009) International diagnostic accuracy study for the serological detection of chikungunya virus infection. Clin Microbiol Infect 15: 880–884. doi: 10.1111/j.1469-0691.2009.02851.x
[23]
Domingo C, Niedrig M, Teichmann A, Kaiser M, Rumer L, et al. (2010) 2nd International external quality control assessment for the molecular diagnosis of dengue infections. PLoS Negl Trop Dis 4: doi: 10.1371/journal.pntd.0000833
[24]
Niedrig M, Donoso Mantke O, Altmann D, Zeller H (2007) First international diagnostic accuracy study for the serological detection of West Nile virus infection. BMC Infect Dis 7: 72. doi: 10.1186/1471-2334-7-72
[25]
Elliott LH, McCormick JB, Johnson KM (1982) Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol 16: 704–708. doi: 10.1371/journal.pntd.0000833
[26]
House C, House JA, Yedloutschnig RJ (1990) Inactivation of viral agents in bovine serum by gamma irradiation. Can J Microbiol 36: 737–740. doi: 10.1139/m90-126
[27]
Nims RW, Gauvin G, Plavsic M (2011) Gamma irradiation of animal sera for inactivation of viruses and mollicutes–a review. Biologicals 39: 370–377. doi: 10.1016/j.biologicals.2011.05.003
[28]
Abe H, Ikebuchi K, Hirayama J, Fujihara M, Takeoka S, et al. (2001) Virus inactivation in hemoglobin solution by heat treatment. Artif Cells Blood Substit Immobil Biotechnol 29: 381–388. doi: 10.1081/BIO-100106921
[29]
Purifoy DJ, Purifoy JA, Sagik BP (1968) A mathematical analysis of concomitant virus replication and heat inactivation. J Virol 2: 275–280.
[30]
Wolfel R, Paweska JT, Petersen N, Grobbelaar AA, Leman PA, et al. (2007) Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis 13: 1097–1100. doi: 10.3201/eid1307.070068
[31]
Wolfel R, Paweska JT, Petersen N, Grobbelaar AA, Leman PA, et al. (2009) Low-density macroarray for rapid detection and identification of Crimean-Congo hemorrhagic fever virus. J Clin Microbiol 47: 1025–1030. doi: 10.1128/JCM.01920-08
[32]
Drosten C, Gottig S, Schilling S, Asper M, Panning M, et al. (2002) Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol 40: 2323–2330. doi: 10.1128/JCM.40.7.2323-2330.2002
[33]
Midilli K, Gargili A, Ergonul O, Elevli M, Ergin S, et al. (2009) The first clinical case due to AP92 like strain of Crimean-Congo Hemorrhagic Fever virus and a field survey. BMC Infect Dis 9: 90. doi: 10.1186/1471-2334-9-90
[34]
Papa A, Drosten C, Bino S, Papadimitriou E, Panning M, et al. (2007) Viral load and Crimean-Congo hemorrhagic fever. Emerg Infect Dis 13: 805–806. doi: 10.3201/eid1305.061588
[35]
Rodriguez LL, Maupin GO, Ksiazek TG, Rollin PE, Khan AS, et al. (1997) Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg 57: 512–518.
[36]
Schwarz TF, Nsanze H, Longson M, Nitschko H, Gilch S, et al. (1996) Polymerase chain reaction for diagnosis and identification of distinct variants of Crimean-Congo hemorrhagic fever virus in the United Arab Emirates. Am J Trop Med Hyg 55: 190–196.
[37]
Deyde VM, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST (2006) Crimean-Congo hemorrhagic fever virus genomics and global diversity. J Virol 80: 8834–8842. doi: 10.1128/JVI.00752-06
[38]
Burt FJ, Leman PA, Smith JF, Swanepoel R (1998) The use of a reverse transcription-polymerase chain reaction for the detection of viral nucleic acid in the diagnosis of Crimean-Congo haemorrhagic fever. J Virol Methods 70: 129–137. doi: 10.1016/S0166-0934(97)00182-1
[39]
Burt FJ, Swanepoel R (2005) Molecular epidemiology of African and Asian Crimean-Congo haemorrhagic fever isolates. Epidemiol Infect 133: 659–666. doi: 10.1017/S0950268805003730
[40]
Duh D, Saksida A, Petrovec M, Ahmeti S, Dedushaj I, et al. (2007) Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis 13: 1769–1772. doi: 10.3201/eid1311.070222
[41]
Cevik MA, Erbay A, Bodur H, Eren SS, Akinci E, et al. (2007) Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis 45: e96–100. doi: 10.1086/521244
